Skip to main content
SpringerLink
Log in

Flucloxacillin associated cholestatic hepatitis

An Australian and Swedish epidemic?

  • Pharmacoepidemiology And Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

The clinico-pathological entity of flucloxacillin-associated cholestatic hepatitis is described and the recognition and documentation of cholestasis associated with flucloxacillin and with related isoxazolyl-penicillins (cloxacillin, dicloxacillin) is examined on an international basis, with particular reference to Australia. Data were obtained from the literature, from the Australian adverse drug reaction monitoring agency and from the Collaborative Centre for International Drug Monitoring (World Health Organisation) in Sweden. Approximately 600 cases of flucloxacillin-associated cholestatic hepatitis were collected, as well as 164 cases associated with other isoxazolyl penicillins.

Jaundice and pruritus may first appear several weeks after administration of the drug has ceased and typically are severe and protracted. Liver tests may be abnormal for months after symptomatic recovery. Death is uncommon. Liver pathology shows centrizonal bile stasis with portal tract inflammation and variable loss of bile ducts. Approximately 1 in 15,000 users of flucloxacillin will develop the reaction. Increasing age (>55 years) and prolonged intake (>14 days) are particular risk factors. Cholestasis associated with cloxacillin/dicloxacillin appears to be similar in nature but is less well defined. Recognition and reporting of the reaction have been uncommon in the United Kingdom inter alia and high in Sweden and Australia, although estimates of risk have been similar. In Australia, the remarkably high rate of reports appears to be the result of sustained publicity for the reaction. There is only a trickle of reports of cholestatic hepatitis in association with the use of cloxacillin and dicloxacillin from the USA and Canada. The high level of awareness of the reaction and consequential regulatory action so far have not resulted in a diminution of its occurrence in Australia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hoigne R, Keller H, Sonntag (1988) Penicillins, cephaslosporins and tetracyclines. In: Dukes MNG, (ed). Meyler's side effects of drugs. Elsevier, Amsterdam, pp 501–542

    Google Scholar 

  2. Tem pas A, Quinn EL (1965) Cholestatic hepatitis following the administration of sodium oxacillin. JAMA 191:138–139

    Google Scholar 

  3. Berger M, Potter DE (1977) Pitfalls in diagnosis of viral hepatitis on a haemodialysis unit. Lancet 2:95–96

    Google Scholar 

  4. Enat R, Pollak S, Ben-Areh Y, Livni E, Baszilai D (1980) Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatic toxic drugs. Br Med J 1:982–983

    Google Scholar 

  5. Onorato IM, Axelrod JL (1978) Hepatitis from intravenous high dose oxacillin therapy: findings in an adult inpatient population. Ann Intern Med 89:497–499

    Google Scholar 

  6. Pollak AA, Berger SA, Simberkoff MS, Rahal Jr JJ (1978) Hepatitis associated with high dose oxacillin therapy. Arch Intern Med 138:195–197

    Google Scholar 

  7. Bengtsson F, Floren CH, Hagerstrand I, Soderstrom C, Aberg T (1985) Flucloxacillin induced cholestatic liver damage. Scand J Infect Dis 17:125–128

    Google Scholar 

  8. Victorino RMM, Maria BA, Correia AP, de Moura C (1987) Flucloxacillin induced cholestatic hepatitis with evidence of lymphocyte sensitisation. Arch intern Med 147:987–989

    Google Scholar 

  9. Deboever G (1987) Cholestatic jaundice due to derivatives of oxacillin (letter) Am J Gastroenterol 82:483

    Google Scholar 

  10. Turner IB, Eckstin RP, Riley JW, Lunzer MR (1989) Prolonged hepatic cholestasis after flucloxacillin therapy. Med J Austr 151:701–705

    Google Scholar 

  11. Miros M, Kerlin P, Walker N, Harris O (1990) Flucloxacillin induced delayed cholestatic hepatitis. Aust NZ J Med 20:251–253

    Google Scholar 

  12. Swedish Adverse Drug Reactions Advisory Committee Bulletin (1989) Flucloxacillin and liver damage. No 54

  13. Australian Adverse Durg Reactions Bulletin (1990) Flucloxcillin hepatitis. February

  14. Australian Adverse Drug Reactions Bulletin (1990) Flucloxacillin hepatitis. November

  15. Committee on Safety of Medicines (1992) Flucloxacillin induced cholestatic jaundice. Current Problems No. 35, Nov.2

  16. Australian Adverse Drug Reactions Bulletin (1992) Update on flucloxacillin hepatitis. February

  17. Adverse Drug Reactions Advisory Committee of the Australian Drug Evaluation Committee (1992) Drug induced cholestatic hepatitis common antibiotics. Med J Austr 157:531

    Google Scholar 

  18. Olsson R, Wiholm BE, Sand C, Zettergren L, Hultcrantz R, Myrhed M (1992) Liver damage from flucloxacillin, cloxacillin and dicloxacillin. J Hepatol 15:154–161

    Google Scholar 

  19. Fairley CK, Boyd I, Purcell P, McNeil J (1992) Flucloxacillin jaundice (Letter). Lancet 339:679

    Google Scholar 

  20. Australian Adverse Drug Reactions Bulletin (1994) Fatal hepatic reactions to flucloxacillin. August

  21. Lobatto S, Dijkmans BAC, Mattie M, Van Hooff JP (1982) Flucloxacillin associated liver damage. Neth J Med 25:47–48

    Google Scholar 

  22. Tauris P, Jorgensen NF, Petersen CM, Albertsen K (1985) Prolonged severe cholestasis induced by oxacillin derivatives. Acta Med Scand 217:567–569

    Google Scholar 

  23. Eckstein RP, Dowsett JF, Lunzer MR (1993) Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy. Pathology 25:223–228

    Google Scholar 

  24. Davies MH, Harrison RF, Elias E, Hübscher SG (1994) Antibiotic-associated acute vanishing bileduct syndrome: a pattern associated with severe, prolonged intrahepatic cholestasis. J Hepatol 20:112–116

    Google Scholar 

  25. Fairley CK, MacNeill JJ, Desmond P, Smallwood R, Young H, Forbes A, et al (1993) Risk factors for development for flucloxacillin associated jaundice. Br Med J 306:233–235

    Google Scholar 

  26. Derby LE, Jick H, Henry DA, Dean AD (1993) Cholestatic hepatitis associated with flucloxacillin. Med J Austr 158: 596–600

    Google Scholar 

  27. Australian Drug Evaluation Committee (1987) Report of suspected adverse drug reactions No. 6. Aust Govt Publishing Service, Canberra

    Google Scholar 

  28. Derby LE, Jick H, Henry DA, Dean AD (1993) Erythromycin-associated cholestatic hepatitis. Med J Austr 158:600–602

    Google Scholar 

  29. Keller H, Follath F (1988) Miscellaneous antibiotics. In: Dukes MNG (ed) Meyler's side effects of drugs. Elsevier Amsterdam, pp 543–566

    Google Scholar 

  30. Jick H, Desley LE, Dean AD, Henry DA (1994) Flucloxacillin and cholestatic hepatitis. Med J Austr 160:525

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, The University of Queensland, Royal Brisbane Hospital, 4029, Queensland, Australia

    D. H. G. Crawford & H. P. Roeser

  2. Department of Medicine, Royal Brisbane Hospital, 4029, Queensland, Australia

    B. M. Devereaux

  3. Queensland Institute of Medical Research, Royal Brisbane Hospital, 4029, Queensland, Australia

    L. W. Powell

  4. Adverse Drug Reactions Section, Drug Safety and Evaluation Branch, Therapeutics Goods Administration, 2601, Canberra, ACT, Australia

    P. Purcell

Authors
  1. D. H. G. Crawford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. P. Roeser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. M. Devereaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. W. Powell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Purcell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crawford, D.H.G., Roeser, H.P., Devereaux, B.M. et al. Flucloxacillin associated cholestatic hepatitis. Eur J Clin Pharmacol 49, 81–85 (1995). https://doi.org/10.1007/BF00192363

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00192363

Key words

Search

Navigation